Apricus Biosciences (APRI)

3.24 +0.22  +7.28%  May 17, 8:00PM
Add to Watchlists Create an Alert

Apricus Biosciences Revenue Quarterly YoY Growth:

1880% for Dec. 31, 2012
View Full Chart

Apricus Biosciences Revenue Quarterly YoY Growth Chart

    Apricus Biosciences Historical Revenue Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 1880%
    Sept. 30, 2012 544.4%
    June 30, 2012 -92.50%
    March 31, 2012 -50.76%
    Dec. 31, 2011 -88.46%
    Sept. 30, 2011 -26.62%
    June 30, 2011 8.45%
    March 31, 2011 9.77%
    Dec. 31, 2010 251.0%
    Sept. 30, 2010 894.1%
    June 30, 2010 1333%
    March 31, 2010 -41.39%
    Dec. 31, 2009 -91.58%
    Sept. 30, 2009 -64.18%
    June 30, 2009 -91.45%
    March 31, 2009 159.2%
    Dec. 31, 2008 767.2%
    Sept. 30, 2008 3.22%
    June 30, 2008 323.3%
    March 31, 2008 Go Pro
       
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro

    About Revenue Growth

    Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.

    If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
    Learn More

    Get data for

    APRI Revenue Quarterly YoY Growth Benchmarks

    Companies
    Warner Chilcott -5.26%
    POZEN -98.15%
    Pernix Therapeutics -14.98%

    APRI Revenue Quarterly YoY Growth Rankings

    Overall 99th percentile
    18 of 7590
    Sector 98th percentile
    8 of 651 in Healthcare
    Industry 95th percentile
    3 of 65 in Drug Manufacturers - Specialty & Generic

    APRI Revenue Quarterly YoY Growth Range, Past 5 Years

    Minimum -92.50% Jun 2012
    Maximum 1880% Dec 2012
    Average 296.2%